Solution structure and neutralizing antibody binding studies of domain III of the dengue-2 virus envelope protein
Solution structure and neutralizing antibody binding studies of domain III of the dengue-2 virus envelope protein
复制标题
DOI:
10.1002/prot.21806
复制
发表时间:
2008-02-15
影响因子:
2.9
通讯作者:
Cheng, Jya-Wei
中科院分区:
文献类型:
--
作者:
Huang, Kuo-Chun;Lee, Ming-Che;Cheng, Jya-Wei
Flaviviruses are small (50 nm) positive-strand RNA viruses that contain a lipid-bilayer membrane. Forty species of the flavivirus family have been associated with human diseases and most of them are transmitted to their vertebrate hosts by infected mosquitoes or ticks. 1 Among these, yellow fever (YF), Japanese encephalitis (JE), tick-borne encephalitis (TBE), and dengue (DEN) are the most important viral arboviruses in the world. DEN viral infections affect more than 100 million populations per year. There has been a marked increase of this disease over the last decades associated with significant mortality. 2 Like other flaviviruses, the virion of DEN contains three structural proteins—a 12 kD nucleocapsid or core protein (C), a 8 kD nonglycosylated membrane protein (M), and a 53 kD glycosylated envelope protein (E), as well as seven nonstructural proteins (NS1, NS2A, NS2B, NS3, NS4A, NS4B, NS5). 3 The E protein is the dominant antigen in eliciting neutralizing antibodies and plays an important role in viral attachment, fusion, penetration, hemagglutination, host range and cell tropism, and virus virulence and attenuation. 1 The three-dimensional structures of the DENV-2, DENV-3, and TBEV E proteins have been determined by X-ray crystallography. 4–6 The X-ray structures reveal that the E protein is composed of three discernible domains, Domain I, II, and III. The solution structures of the Domain III of JEV, LGTV, WNV, and DENV-4 envelope proteins have been studied recently. 7–11 Monoclonal antibodies that bind to Domain III of DENV are found to be the most efficient blockers of virus adsorption to vero cells. 12 However, no detailed spatial configuration of the epitopes of Domain III of DENV E protein has been provided. In here we have determined the solution structure of the domain III of the DENV-2 E protein. Moreover, we have identified the neutralizing epitopes of the DENV-2 Domain III to its specific neutralization antibody (mAb 137-22) by site-directed mutagenesis. Our results provide a structural basis for understanding the mechanism of immunologic protection and for rational design of vaccines effective against DEN viruses.